Stockscreener 앱 받기
0.7201
2.70%
-0.02
시간 외 거래:
.76
0.0399
+5.54%
Gossamer Bio Inc 주식(GOSS)의 최신 뉴스
After Plunging -20% in 4 Weeks, Here's Why the Trend Might Reverse for Gossamer Bio (GOSS) - Yahoo Finance
Leerink Partnrs Raises Earnings Estimates for Gossamer Bio - MarketBeat
After Plunging -15.92% in 4 Weeks, Here's Why the Trend Might Reverse for Gossamer Bio (GOSS) - Yahoo Finance
HC Wainwright Increases Earnings Estimates for Gossamer Bio - MarketBeat
FMR LLC's Strategic Acquisition of Gossamer Bio Inc Shares - GuruFocus.com
Industry Analysts Just Made A Sizeable Upgrade To Their Gossamer Bio, Inc. (NASDAQ:GOSS) Revenue Forecasts - Yahoo Finance
Gossamer Bio (GOSS) Reports Q3 Loss, Tops Revenue Estimates - MSN
Gossamer Bio Grants 183K Stock Options to New Hires at $0.88 Per Share | GOSS Stock News - StockTitan
Gossamer Bio (NASDAQ:GOSS) Earns Buy Rating from HC Wainwright - MarketBeat
Gossamer Bio, Inc. (NASDAQ:GOSS) Just Reported And Analysts Have Been Lifting Their Price Targets - Yahoo Finance
Gossamer Bio Reports Revenue Growth Amid Strategic Collaborations - TipRanks
Gossamer Bio: Q3 Earnings Snapshot - Houston Chronicle
GOSSGossamer Bio, Inc. Latest Stock News & Market Updates - StockTitan
Gossamer Bio Announces Third Quarter 2024 Financial Results and Provides Business Update - Business Wire
Presenting on the Emerging Growth Conference 76 Day 2 on October 31 Register Now - The Manila Times
Gossamer Bio, Inc. (NASDAQ:GOSS) Short Interest Update - MarketBeat
Gossamer Bio, Inc. (NASDAQ:GOSS) Sees Large Decline in Short Interest - Defense World
3 US Penny Stocks With Market Caps Under $900M To Consider - Simply Wall St
Gossamer Bio, Inc. (NASDAQ:GOSS) Shares Bought by The Manufacturers Life Insurance Company - Defense World
Hypertension Clinical Trials 2024: FDA Approvals, Medication, Therapies, MOA, ROA, Companies by DelveInsight | Quantum Genomics, CinCor Pharma, Mineralys Therapeutics, Alnylam Therapeutics, Novartis - The Globe and Mail
It makes sense and dollars to buy Gossamer Bio Inc (GOSS) stock - SETE News
Financial Fitness Check: Examining Gossamer Bio Inc (GOSS)’s Key Ratios - The Dwinnex
Gossamer Bio Inc (GOSS) rating initates by Oppenheimer - Knox Daily
Millennium Management LLC Sells 898,042 Shares of Gossamer Bio, Inc. (NASDAQ:GOSS) - MarketBeat
Gossamer Bio, Inc. (NASDAQ:GOSS) Shares Sold by Millennium Management LLC - MarketBeat
The Attractiveness of Investing In Gossamer Bio Inc (GOSS) is Growing - Knox Daily
Investor’s Delight: Gossamer Bio Inc (GOSS) Closes Weak at 1.02, Down -2.86 - The Dwinnex
GOSS underperforms with a -2.86 decrease in share price - US Post News
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - BioSpace
Gossamer Bio Inc [NASDAQ: GOSS] Sees Decrease in Stock Value - Knox Daily
Marshall Wace LLP Boosts Position in Gossamer Bio, Inc. (NASDAQ:GOSS) - MarketBeat
Several Insiders Invested In Gossamer Bio Flagging Positive News - Yahoo Finance
Analyzing Northwest Biotherapeutics (OTCMKTS:NWBO) and Gossamer Bio (NASDAQ:GOSS) - Defense World
Navigating GOSS’s Stock Market Maze: Ups and Downs in 2023 - The InvestChronicle
A better buy-in window may exist right now for Gossamer Bio Inc (GOSS) - SETE News
Gossamer Bio, Inc. (NASDAQ:GOSS) Short Interest Down 5.8% in September - Defense World
Analysts review Gossamer Bio Inc’s rating - Knox Daily
GOSS (Gossamer Bio Inc) has impressive results - US Post News
A company insider recently sold 1,908 shares of Gossamer Bio Inc [GOSS]. Should You Sale? - Knox Daily
GoDaddy (NYSE:GDDY) PT Raised to $185.00 at Barclays - MarketBeat
It makes sense and dollars to buy Gevo Inc (GEVO) stock - SETE News
Gaining Ground: Gossamer Bio Inc (GOSS) Closes Lower at 0.99, Down -0.61 - The Dwinnex
NEA Management Company LLC Buys 2,255,025 Shares of Gossamer Bio, Inc. (NASDAQ:GOSS) - Defense World
Keeping an Eye on Globus Medical Inc (GMED) After Insider Trading Activity - Knox Daily
Presenting on the Emerging Growth Conference 75 Day 2 on September 26 - GlobeNewswire
Analysts review Godaddy Inc’s rating - Knox Daily
A significant driver of top-line growth: Gossamer Bio Inc (GOSS) - SETE News
Is GlycoMimetics Inc (GLYC) a threat to investors? - US Post News
Globus Medical's (NYSE:GMED) investors will be pleased with their favorable 42% return over the last year - Yahoo Finance
Piper Sandler Downgrades GoDaddy (GDDY) - MSN
GOSS stock rated an Outperform by Oppenheimer - Knox Daily
Examining GOSS’s book value per share for the latest quarter - US Post News
GoDaddy downgraded by Piper Sandler with a new price target - Quantisnow
Gossamer Bio's Market Cap Up US$29m Following Year Of Insider Stock Buying - Simply Wall St
Choreo LLC Makes New Investment in Gossamer Bio, Inc. (NASDAQ:GOSS) - Defense World
GOSS Stock on the Rise: A Promising Investment - The InvestChronicle
Federated Hermes Inc. Has $2.76 Million Holdings in Gossamer Bio, Inc. (NASDAQ:GOSS) - Defense World
Gossamer Bio shares maintain Buy rating on additional trial data By Investing.com - Investing.com Australia
3.66%
1.11%
자본화:
|
볼륨(24시간):